CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

When it comes to the outlook for multiple sclerosis (MS), there’s both good news and bad news. Although MS isn’t fatal, there’s currently no cure — MS is a chronic condition. But many ...

Disc Medicine, Inc. (NASDAQ:IRON), a biotechnology company focused on developing treatments for rare blood disorders, has ...

ProMIS Neurosciences Inc. (Nasdaq: PMN) (ProMIS), a clinical-stage biotechnology company focused on the generation and ...

Total Liabilities Shareholders' Equity 4,80,196.57 4,47,913.25 4,24,945.90 3,98,887.64 ...

Containment of the Eaton Fire has risen to 55% despite as firefighter take advantage of a slight break from Santa Ana wind ...

First-in-class oral selective SMARCA2 (BRM) inhibitor, FHD-909 (LY4050784), advancing in Phase 1 trial for SMARCA4 mutated cancers, with ...

What has been each team's best surprise in the first half? The Athletic posed that question this week to its NHL staff.

The department's report concluded that "the facility failed to protect and promote each patient's rights ... He was later found to have multiple fractured ribs and a fractured right tibia ...

The Public Affairs team will work with you to obtain necessary clearance for on-site visits. Stories involving UCSF Health patients require advance HIPAA (Health Insurance Portability and ...

Agios Pharma submitted a sNDA to the FDA after two Phase III trials studying PYRUKYND (mitapivat) in thalassemia met their ...

Multiple patients of Jefferson Radiology clinics tell the I-Team they have been waiting weeks for answers. One of the patients that reached out is Vanetta Hayhurst. “I tend to be the type of ...